Etoposide

NDC 63323-104 · Fresenius Kabi USA, LLC

Generic nameETOPOSIDE

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)ETOPOSIDE

Strength20 mg/mL

Pharmacologic classTopoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]

Marketing categoryANDA

Packages

63323-104-05 — 10 BOX in 1 CARTON (63323-104-05) / 1 VIAL, MULTI-DOSE in 1 BOX (63323-104-01) / 5 mL in 1 VIAL, MULTI-DOSE

63323-104-06 — 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-06) / 5 mL in 1 VIAL, MULTI-DOSE

63323-104-25 — 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-25) / 25 mL in 1 VIAL, MULTI-DOSE

63323-104-50 — 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-50) / 50 mL in 1 VIAL, MULTI-DOSE

J9181 — Injection, etoposide, 10 mg Medicare Part B payment limit (ASP + 6%): $1.02

FDA lists these products with the same active ingredient.

0143-9376 — Etoposide, 0143-9510 — Etoposide, 0143-9511 — Etoposide, 0143-9512 — Etoposide, 0378-3266 — etoposide, 16729-114 — Etoposide, 68001-265 — Etoposide, 68001-681 — Etoposide, 68001-682 — Etoposide, 68001-683 — Etoposide, 69238-2811 — Etoposide, 71288-175 — Etoposide, 71288-176 — Etoposide, 71288-177 — Etoposide, 83270-451 — ETOPOSIDE, 83831-144 — etoposide, 83831-145 — etoposide

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.